10-K/A

BIOTIME, INC 10-KA 12-31-2013

Company: Lineage Cell Therapeutics, Inc.
Filed: April 29, 2014
Period of Report: December 31, 2013
Accession Number: 0001140361-14-017874

View Document ↗ View on SEC.gov ↗